Informed Consent Notice
(For those involved in research and surveys for medical staff)
We invite you to participate in a survey conducted by the Sichuan Provincial Cancer Hospital under the "Research on the Establishment of a Patient Reporting System for Disease Monitoring - PRO-SMA." The research has received approval from the hospital's review committee. Please read this consent form carefully.
I. Research Background:
Esophageal cancer is the sixth most common malignancy and a leading cause of cancer-related death. Medical professionals experience significant job stress, leading to burnout. A 2020 Medscape survey of over 15,000 doctors found that long hours and heavy workloads are major stress factors, with 42% of doctors reporting high stress levels.
In response, we have implemented the PRO-SMA system to help manage the workload of medical staff, particularly in high-demand departments like thoracic surgery, improving both physician well-being and patient care.
II. Research Purpose:
The study uses the MBI-HSS scale to evaluate medical staff's working conditions, patient care time, external consultations, communication methods, and stress levels across hospital levels.
III. Research Process:
If you participate, you will complete a survey about medical staff managing cancer patients.
IV. Risks:
There are no significant risks other than minor inconvenience from completing the survey.
V. Your Benefits:
Participating may help improve cancer patient management in the future.
VI. Your Responsibility:
You are responsible for completing the survey.
VII. Your Rights:
If you have questions or concerns during the study, contact Ms. Longlin. If your rights are violated, you can contact the hospital’s review committee at 028-85420681.
VIII. Privacy Issues:
Your personal information will be kept confidential. Data will only be accessible to the research team and stored securely. No personal data will be disclosed when the results are published.
Please sign in the rectangular box below. Once completed, click "Confirm" and upload your signature.